Human Embryonic Stem Cell (hESC) Lines
- CIRM's list of acceptably derived lines: Research institutions have certified these lines are derived in accordance with CIRM regulations. All listed line are eligible for use in CIRM-funded research.
- Lines previously approved by NIH prior to March 2009: All listed lines are eligible for use in CIRM-funded research.
- NIH Human Embryonic Stem Cell Registry: All listed line are eligible for use in CIRM-funded research.
- UK Stem Cell Bank: All listed lines are eligible for use in CIRM-funded research.
- BioTime Lines: CIRM has previously entered into a letter of agreement with Biotime to provide research grade human embryonic stem cell lines to California researchers. This MTA has expired. Please contact Biotime to negotiate a similar agreement. Biotimes cell lines ESI-014, ESI-017, ES1-035, ES1- 051 & ES1- 053 are listed on the NIH Human Embryonic Stem Cell Registry and therefore eligible for use in CIRM-funded research. The complete genome sequence files for those lines is available on the BioTime homepage.
Latest Press Releases
CIRM-funded research programs are helping turn stem cells into cures. Browse our press release archive below to find out the latest advances. For even more breaking news, visit our blog, The Stem Cellar.
May 31, 2023
Apr 27, 2023
Apr 11, 2023
Mar 27, 2023
CIRM holds regular scientific workshops and meetings to update the scientific staff and CIRM grantees about particular areas of stem cell and related research.
- Engineering Strategies, Opportunities, and Challenges for Tissue Repair and Regeneration: CIRM Workshop Summary and Recommendati [pdf]
- Cell Therapies for Parkinson’s Disease from Discovery to Clinic [pdf]
- Alpha Stem Cell Clinics: Delivering a New Kind of Medicine [pdf]
- Cerebral Palsy Workshop Report [pdf]